AFP and hepatocellular carcinoma: Correspondingly, the overall survival rates for the ANHC group were 94.4%, 83.8%, and 62.3%, respectively, and those for the AFP-positive group were 87.2%, 60.0%, and 36.7%, respectively.25 Therefore, diagnosing ANHC is essential to improving prognosis for HCC patients.